209 related articles for article (PubMed ID: 7728738)
21. The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).
Taucher S; Steger GG; Jakesz R; Tausch C; Wette V; Schippinger W; Kwasny W; Reiner G; Greil R; Dubsky P; Poestlberger S; Tschmelitsch J; Samonigg H; Gnant M;
Breast Cancer Res Treat; 2008 Nov; 112(2):309-16. PubMed ID: 18080748
[TBL] [Abstract][Full Text] [Related]
22. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
[TBL] [Abstract][Full Text] [Related]
23. Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol INT-0102.
Hutchins LF; Green SJ; Ravdin PM; Lew D; Martino S; Abeloff M; Lyss AP; Allred C; Rivkin SE; Osborne CK
J Clin Oncol; 2005 Nov; 23(33):8313-21. PubMed ID: 16293862
[TBL] [Abstract][Full Text] [Related]
24. Alterations in the erythrocyte antioxidant system of blood stored in blood bags.
Korgun DK; Bilmen S; Yesilkaya A
Res Commun Mol Pathol Pharmacol; 2001; 109(5-6):357-63. PubMed ID: 12889518
[TBL] [Abstract][Full Text] [Related]
25. [CMF or CAF combination chemotherapy for breast cancer].
Ota J
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1886-90. PubMed ID: 8978791
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89.
Ejlertsen B; Mouridsen HT; Jensen MB
Acta Oncol; 2008; 47(4):662-71. PubMed ID: 18465334
[TBL] [Abstract][Full Text] [Related]
27. [Activity of antioxidant protection enzymes and content of lipid peroxidation products in blood serum and cerebrospinal fluid in patients with ischemic brain disease].
Dzhandzhgava TG; Shakarishivili RR
Vopr Med Khim; 1992; 38(2):33-5. PubMed ID: 1413627
[TBL] [Abstract][Full Text] [Related]
28. Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Group.
de Haes H; Olschewski M; Kaufmann M; Schumacher M; Jonat W; Sauerbrei W;
J Clin Oncol; 2003 Dec; 21(24):4510-6. PubMed ID: 14610048
[TBL] [Abstract][Full Text] [Related]
29. [Primary chemotherapy of metastatic breast carcinoma with bendamustine hydrochloride, methotrexate and fluorouracil versus cyclophosphamide, methotrexate and fluorouracil].
Ruffert K
Zentralbl Chir; 1998; 123 Suppl 5():156-8. PubMed ID: 10063603
[TBL] [Abstract][Full Text] [Related]
30. [Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan].
Nomura Y; Tominaga T; Adachi I; Koyama H; Fukami A
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1949-56. PubMed ID: 8085846
[TBL] [Abstract][Full Text] [Related]
31. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y
J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of antioxidant status and oxidative stress in cattle naturally infected with Theileria annulata.
Asri Rezaei S; Dalir-Naghadeh B
Vet Parasitol; 2006 Nov; 142(1-2):179-86. PubMed ID: 16901649
[TBL] [Abstract][Full Text] [Related]
33. Effect of the herbicide 4-CPA on human erythrocyte antioxidant enzymes in vitro.
Alicigüzel Y; Ozdem S; Demir AY; Unal F; Kumbul D; Ozdem SS; Perry G; Smith MA
Redox Rep; 2001; 6(3):153-4. PubMed ID: 11523589
[TBL] [Abstract][Full Text] [Related]
34. Lipid peroxidation of erythrocytes in visceral leishmaniasis.
Biswas T; Ghosh DK; Mukherjee N; Ghosal J
J Parasitol; 1997 Feb; 83(1):151-2. PubMed ID: 9057713
[TBL] [Abstract][Full Text] [Related]
35. [Effect of sodium nitrite poisoning on the activity of enzymes of anti-oxidant protection and peroxidation processes in mouse erythrocytes].
Shugaleĭ IV; L'vov SN; Tselinskiĭ IV; Baev VI
Ukr Biokhim Zh (1978); 1992; 64(2):111-4. PubMed ID: 1413109
[TBL] [Abstract][Full Text] [Related]
36. The activities of superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase in erythrocytes of rats with experimental neoplastic disease.
Batko J; Warchoł T; Karoń H
Acta Biochim Pol; 1996; 43(2):403-5. PubMed ID: 8862187
[TBL] [Abstract][Full Text] [Related]
37. Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B.
Demirdag K; Yilmaz S; Ozdarendeli A; Ozden M; Kalkan A; Kilic SS
Hepatogastroenterology; 2003; 50(51):766-70. PubMed ID: 12828081
[TBL] [Abstract][Full Text] [Related]
38. Glutathione redox cycle enzyme activities in erythrocytes of multiple sclerosis patients.
Di Ilio C; Arduini A; Del Boccio G; La Rovere G; Federici G
Clin Physiol Biochem; 1986; 4(2):120-4. PubMed ID: 3698470
[TBL] [Abstract][Full Text] [Related]
39. Changes in erythrocyte membrane lipids in breast cancer after radiotherapy and chemotherapy.
Vasigara Singh W; Subramaniam S; Shyama S; Jagadeesan M; Shyamala Devi CS
Chemotherapy; 1996; 42(1):65-70. PubMed ID: 8751268
[TBL] [Abstract][Full Text] [Related]
40. [Comparison of adjuvant chemotherapy in breast carcinoma with a combination of cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and AC (doxorubicin, cyclophosphamide). Initial results of a national cooperative study].
Pribylová O; Petruzelka L; Honová H; Fischer J; Bustová I; Siffnerová H; Kůta M; Miller V; Hacklová M; Machácek J; Kohoutek M; Vodvárka P; Kyselá T; Tajblová J; Suk J; Dorazilová V; Bauer J
Sb Lek; 1998; 99(1):25-31. PubMed ID: 9748796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
